NCT00019630View on ClinicalTrials.gov

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Conditions
Childhood Soft Tissue SarcomaChildhood Liver CancerBone CancerBrain TumorKidney Tumor
Interventions
DRUG

doxorubicin HCl liposome

Trial Locations (2)

19104

Children's Hospital of Philadelphia, Philadelphia

20892

Pediatric Oncology Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019630 - Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter